{
  "title": "Paper_873",
  "abstract": "pmc Microorganisms Microorganisms 3054 microorg microorganisms Microorganisms 2076-2607 Multidisciplinary Digital Publishing Institute  (MDPI) PMC12472085 PMC12472085.1 12472085 12472085 41011399 10.3390/microorganisms13092067 microorganisms-13-02067 1 Article Comprehensive Safety Assessment of Lentilactobacillus buchneri KU200793 Kim Suin Methodology Software Validation Formal analysis Investigation Data curation Writing – original draft Visualization 1 https://orcid.org/0009-0006-7216-8648 Jeong Huijin Software Validation Investigation Data curation 1 Lee Na-Kyoung Methodology Software Validation Investigation 2 https://orcid.org/0000-0001-9241-1250 Kang Dae-Kyung 3 https://orcid.org/0000-0001-9891-7703 Paik Hyun-Dong 2 https://orcid.org/0000-0002-9930-4201 Park Young-Seo Conceptualization Methodology Investigation Resources Writing – review & editing Supervision Project administration 1 * https://orcid.org/0000-0002-3083-7595 Lee Jong Hun Conceptualization Methodology Investigation Resources Writing – review & editing Supervision Project administration Funding acquisition 1 * Varzakas Theodoros Academic Editor 1 sue030465@gachon.ac.kr huijin0218@gmail.com 2 nakyoung_lee@nate.com hdpaik@konkuk.ac.kr 3 dkkang@dankook.ac.kr * ypark@gachon.ac.kr foodguy@gachon.ac.kr 05 9 2025 9 2025 13 9 496716 2067 29 7 2025 29 8 2025 03 9 2025 05 09 2025 27 09 2025 29 09 2025 © 2025 by the authors. 2025 https://creativecommons.org/licenses/by/4.0/ Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ( https://creativecommons.org/licenses/by/4.0/ The safety profile of Lentilactobacillus buchneri KU200793 L. buchneri KU200793 tetA 58 nalD L. buchneri KU200793 L. buchneri KU200793 genotypic analysis Lentilactobacillus buchneri neuroprotective effects phenotypic analysis probiotics safety evaluation Gachon University GCU-202406430001 Ministry of Agriculture, Food, and Rural Affairs (MAFRA) 321035052HD020 This research was funded by the Gachon University research fund of 2024 (GCU-202406430001) and the Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, and Forestry (IPET) through the High Value-Added Food Technology Development Program funded by the Ministry of Agriculture, Food, and Rural Affairs (MAFRA) (grant number 321035052HD020). pmc-status-qastatus 0 pmc-status-live yes pmc-status-embargo no pmc-status-released yes pmc-prop-open-access yes pmc-prop-olf no pmc-prop-manuscript no pmc-prop-legally-suppressed no pmc-prop-has-pdf yes pmc-prop-has-supplement no pmc-prop-pdf-only no pmc-prop-suppress-copyright no pmc-prop-is-real-version no pmc-prop-is-scanned-article no pmc-prop-preprint no pmc-prop-in-epmc yes 1. Introduction Lactic acid bacteria (LAB) have long been utilized as probiotics in dietary supplements and food products [ 1 2 3 4 5 Despite their potential health benefits, the expanding diversity of LAB and their increasing use as probiotics, particularly strains belonging to the genus Lactobacillus 6 7 8 9 Lentilactobacillus buchneri 10 11 L. buchneri KU200793 L. buchneri KU200793 + L. buchneri KU200793 12 Although this strain was originally isolated from kimchi, a traditional fermented food, L. buchneri KU200793 13 L. buchneri KU200793 14 2. Materials and Methods 2.1. Bacterial Strains and Culture Conditions L. buchneri KU200793 Klebsiella pneumoniae pneumoniae Proteus vulgaris Escherichia coli Streptococcus pneumoniae S. pyogenes S. agalactiae Brevibacillus Br. parabrevis Lactiplantibacillus plantarum Bacillus cereus K. pneumoniae P. vulgaris E. coli Br. parabrevis Lp. plantarum 2.2. Cell Culture Conditions The Caco-2 cell line (ATCC ® 2 v v v v 2.3. Assessment of Hemolytic Activity Hemolytic activity was evaluated by streaking bacteria on blood agar base No. 2 (Sigma-Aldrich, St. Louis, MO, USA) supplemented with 5% sheep blood (KisanBio, Seoul, Republic of Korea). The plates were inoculated with L. buchneri KU200793 S. pneumoniae S. pyogenes S. agalactiae 2.4. Evaluation of Bile Salt Deconjugation Bile salt deconjugation was assessed using MRS containing 0.5% taurodeoxycholic acid (bile acid; Sigma-Aldrich). Plates inoculated with L. buchneri KU200793 B. cereus 2.5. Cytotoxicity Assay Using Caco-2 Cells Caco-2 cells were seeded at a density of 5 × 104 cells/well in a 96-well plate in DMEM supplemented with 10% FBS and 1% penicillin–streptomycin. The cells were incubated at 37 °C in a 5% CO 2 L. buchneri KU200793 K. pneumoniae pneumoniae g v v 15 2 2 16 2.6. Determination of Mucin Degradation L. buchneri KU200793 w v w v w v w v 2.7. Quantification of D-Lactic Acid Production The LAB culture was centrifuged at 16,000× g 2.8. Analysis of Biogenic Amine Production L. buchneri KU200793 w v w v potA–E L. buchneri KU200793 2.9. Antibiotic Susceptibility Test The antibiotic susceptibility of L. buchneri KU200793 14 w v 2.10. Genomic Analysis of Antibiotic Resistance and Virulence Factors The whole-genome sequence of L. buchneri KU200793 https://card.mcmaster.ca/analyze/rgi http://genepi.food.dtu.dk/resfinder 2.11. Gelatin Liquefaction Assay The gelatin liquefaction assay was conducted in MRS medium supplemented with 12% ( w v L. buchneri KU200793 Br. parabrevis 2.12. Urease Activity Assay The urease activity of bacterial cells was assessed by streaking them onto Christensen’s urea agar (0.1 g of peptone, 0.1 g of dextrose, 0.5 g of sodium chloride, 0.2 g of monopotassium phosphate, 2 g of urea, 0.012 g of phenol red) slants. L. buchneri KU200793 P. vulgaris 2.13. Indole Production Assay Indole production was assessed using tryptophan as a substrate. L. buchneri KU200793 E. coli 2.14. Statistical Analysis All experiments were conducted in triplicate, with the results expressed as the mean ± standard deviation (SD). Statistical analyses were performed using SPSS 28 (SPSS Inc., Chicago, IL, USA) software. One-way analysis of variance (ANOVA) was used to evaluate the statistical significance of the results, and Duncan’s multiple range test was used to identify significant differences between groups. A p 3. Results 3.1. Hemolytic Profile of L. buchneri KU200793 S. pneumoniae Figure 1 S. pyogenes Figure 1 S. agalactiae Figure 1 L. buchneri KU200793 Figure 1 3.2. Bile Salt Deconjugation Activity Lp. plantarum Figure 2 L. buchneri KU200793 Figure 2 3.3. Cytotoxic Effects on Caco-2 Cells L. buchneri KU200793 K. pneumoniae pneumoniae L. buchneri KU200793 Figure 3 L. buchneri KU200793 3.4. Mucin Degradation Potential L. buchneri KU200793 w v Figure 4 L. buchneri KU200793 3.5. D-Lactic Acid Production Levels The D-lactic acid production by L. buchneri KU200793 L. buchneri KU200793 Table 1 3.6. Biogenic Amine Production Profile Under our experimental conditions, the analysis of BA production in L. buchneri KU200793 Table 2 3.7. Antibiotic Resistance Pattern The antibiotic resistance of L. buchneri KU200793 L. buchneri KU200793 Figure 5 Table 3 3.8. Genome-Based Identification of Resistance and Virulence Determinants The complete genome sequence of L. buchneri KU200793 L. buchneri KU200793 tetA 58 nalD Table 4 3.9. Gelatin Liquefaction Activity No gelatin liquefaction was observed in the medium inoculated with L. buchneri KU200793 Br. parabrevis 3.10. Urease Activity The urease activity of L. buchneri KU200793 P. vulgaris 3.11. Indole Production L. buchneri KU200793 E. coli 4. Discussion Safety evaluation of probiotic strains is a crucial prerequisite for their commercial application and potential health benefits. Unverified strains present health risks, including opportunistic infections, HGT of antibiotic resistance, and harmful metabolic activities. Therefore, a comprehensive safety assessment—encompassing genome-based screening for ARGs, metabolic profiling, and both in vivo and in vitro toxicity evaluations—is essential. Only strains that meet rigorous safety standards should be considered for probiotic use. L. buchneri L. buchneri KU200793 Hemolytic activity is a key parameter in probiotic safety evaluation, as β-hemolysis is associated with pathogenic potential. Using blood agar assays, L. buchneri KU200793 17 Lactobacillus L. fermentum 18 BSH is widely present in the gut microbiota and contributes to microbial survival, but its activity may generate harmful secondary bile acids linked to adverse health effects [ 19 20 L. buchneri KU200793 L. paracasei paracasei 8 L. buchneri KU200793 L. buchneri KU200793 21 The intestinal mucus layer provides both a favorable niche for microbial survival and a primary barrier against pathogen and toxin entry. Mucin degradation, a known virulence trait of pathogens such as Vibrio cholerae Helicobacter pylori Salmonella Shigella Staphylococcus aureus 22 23 L. rhamnosus L. acidophilus Bifidobacterium lactis 24 Lactococcus lactis 25 In contrast to L-lactic acid, which is efficiently metabolized in humans, D-lactic acid is produced in a strain- and condition-dependent manner and undergoes only limited degradation by intestinal enzymes [ 26 27 28 L. buchneri Lentilactobacillus 29 L. buchneri KU200793 L. lactis 30 L. rhamnosus 26 BAs produced via amino acid decarboxylation are well known to act as neurotransmitters in humans, and spermidine, an endogenous metabolite, additionally plays a crucial role in cell growth, anti-aging, and autophagy [ 31 32 33 34 The spermidine production in L. buchneri KU200793 L. brevis L. paracasei 35 L. buchneri 36 L. buchneri KU200793 cheonggukjang L. buchneri KU200793 37 In nature, antibiotics function as competitive tools among microorganisms, but their indiscriminate use has accelerated the emergence of antimicrobial resistance in both pathogenic and commensal species [ 38 Lactobacillus Lactobacillus 39 40 L. buchneri KU200793 L. salivarius 41 L. lactis 42 L. buchneri KU200793 Antibiotic resistance can arise either intrinsically, through mutations stably inherited within a strain, or via HGT, which poses a greater risk due to the possibility of ARG dissemination to pathogens [ 43 44 45 46 47 L. buchneri KU200793 Gelatinase is a biologically active protease that degrades host proteins such as collagen, casein, and hemoglobin, and its activity has been implicated in bacterial pathogenesis, tissue damage, and the progression of inflammatory diseases such as endocarditis [ 24 48 49 L. buchneri KU200793 Urease is a nickel-dependent metalloenzyme that hydrolyzes urea into carbon dioxide and ammonia, and its activity has been implicated in urinary tract infections, hepatic encephalopathy, and other pathological conditions [ 50 51 H. pylori L. buchneri KU200793 Indole is a nitrogen-containing metabolite generated by microbial tryptophan metabolism via tryptophanase and has been associated with neurotoxic and metabolic effects, including impaired motor function, anxiety, and depression [ 52 52 53 L. buchneri KU200793 Lactobacillus 54 5. Conclusions A comprehensive safety assessment of L. buchneri KU200793 L. buchneri KU200793 Acknowledgments The authors acknowledge the support provided by the Gachon University Research Fund of 2024 (GCU-202406430001) and the Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, and Forestry (IPET) through the High Value-Added Food Technology Development Program funded by the Ministry of Agriculture, Food, and Rural Affairs (MAFRA) (grant number 321035052HD020). Disclaimer/Publisher’s Note: Author Contributions Conceptualization, D.-K.K., H.-D.P., Y.-S.P. and J.H.L.; methodology, S.K., N.-K.L., Y.-S.P. and J.H.L.; software, S.K., H.J. and N.-K.L.; validation, S.K., H.J. and N.-K.L.; formal analysis, S.K.; investigation, S.K., H.J., N.-K.L., Y.-S.P. and J.H.L.; resources, D.-K.K., H.-D.P., Y.-S.P. and J.H.L.; data curation, S.K. and H.J.; writing—original draft preparation, S.K. and H.J.; writing—review and editing, Y.-S.P. and J.H.L.; visualization, S.K.; supervision, Y.-S.P. and J.H.L.; project administration, Y.-S.P. and J.H.L.; funding acquisition, H.-D.P. and J.H.L. All authors have read and agreed to the published version of the manuscript. Institutional Review Board Statement Not applicable. Informed Consent Statement Not applicable. Data Availability Statement The original contributions presented in this study are included in the article. Further inquiries can be directed to the corresponding authors. Conflicts of Interest The authors declare no conflicts of interest. References 1. Koll P. Mändar R. Smidt I. Hütt P. Truusalu K. Mikelsaar R.H. Shchepetova J. Krogh-Andersen K. Marcotte H. Hammarström L. Screening and evaluation of human intestinal lactobacilli for the development of novel gastrointestinal probiotics Curr. Microbiol. 2010 61 560 566 10.1007/s00284-010-9653-y 20443005 2. Gemechu T. Review on lactic acid bacteria function in milk fermentation and preservation Afr. J. Food Sci. 2015 9 170 175 10.5897/ajfs2015.1276 3. FAO/WHO Guidelines for the Evaluation of Probiotics in Food FAO/WHO Working Group FAO Rome, Italy WHO Geneva, Switzerland 2002 1 11 4. Barrea L. Verde L. Auriemma R.S. Vetrani C. Cataldi M. Frias-Toral E. Pugliese G. Camajani E. Savastano S. Colao A. Probiotics and prebiotics: Any role in menopause-related diseases? Curr. Nutr. Rep. 2023 12 83 97 10.1007/s13668-023-00462-3 36746877 PMC9974675 5. Chon J.W. Youn H.Y. Kim H.J. Oh H. Kang S.H. Hwang W.U. Jeong H. Kim H.J. Seo K.H. Song K.Y. Anti-viral activities of probiotics against viral gastroenteritis: A review J. Dairy Sci. Biotechnol. 2023 41 87 102 10.22424/jdsb.2023.41.3.87 6. Lee B.S. Ban O.H. Bang W.Y. Chae S.A. Oh S. Park C. Lee M. Kim S.J. Yang J. Jung Y.H. Safety assessment of Lactobacillus reuteri Ann. Microbiol. 2021 71 10 10.1186/s13213-021-01622-y 7. Sarita B. Samadhan D. Hassan M.Z. Kovaleva E.G. A comprehensive review of probiotics and human health—Current prospective and applications Front. Microbiol. 2025 15 1487641 10.3389/fmicb.2024.1487641 39834364 PMC11743475 8. Chen C.T. Chao W.Y. Lin C.H. Shih T.W. Pan T.M. Comprehensive safety assessment of Lacticaseibacillus paracasei paracasei Curr. Issues Mol. Biol. 2024 46 12354 12374 10.3390/cimb46110734 39590328 PMC11593238 9. Lee M. Bang W.Y. Lee H.B. Yang S.Y. Lee K.S. Kang H.J. Hong S.M. Yang J. Safety assessment and evaluation of probiotic potential of Lactobacillus bulgaricus Microorganisms 2024 12 2063 10.3390/microorganisms12102063 39458372 PMC11510087 10. Nethery M.A. Henriksen E.D. Daughtry K.V. Johanningsmeier S.D. Barrangou R. Comparative genomics of eight Lactobacillus buchneri BMC Genom. 2019 20 902 10.1186/s12864-019-6274-0 PMC6881996 31775607 11. Heinl S. Wibberg D. Eikmeyer F. Szczepanowski R. Blom J. Linke B. Goesmann A. Grabherr R. Schwab H. Pühler A. Insights into the completely annotated genome of Lactobacillus buchneri J. Biotechnol. 2012 161 153 166 10.1016/j.jbiotec.2012.03.007 22465289 12. Cheon M.J. Lim S.M. Lee N.K. Paik H.D. Probiotic properties and neuroprotective effects of Lactobacillus buchneri Int. J. Mol. Sci. 2020 21 1227 10.3390/ijms21041227 32059401 PMC7072984 13. Shokryazdan P. Faseleh Jahromi M. Liang J.B. Kalavathy R. Sieo C.C. Ho Y.W. Safety assessment of two new Lactobacillus PLoS ONE 2016 11 e0159851 10.1371/journal.pone.0159851 27467068 PMC4965145 14. EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) Rychen G. Aquilina G. Azimonti G. Bampidis V. Bastos M.L. Bories G. Chesson A. Cocconcelli P.S. Flachowsky G. Guidance on the characterisation of microorganisms used as feed additives or as production organisms EFSA J. 2018 16 e05206 10.2903/j.efsa.2018.5206 32625840 PMC7009341 15. Lee M.G. Kang M.J. Kim S. Jeong H. Kang D.K. Paik H.D. Park Y.S. Safety assessment of Levilactobacillus brevis Probiotics Antimicrob. Proteins 2024 17 1117 1131 10.1007/s12602-024-10237-z 38430332 16. Tail M. Zhang H. Zheng G. Hatami M. Skutella T. Unterberg A. Zweckberger K. Younsi A. The sonic hedgehog pathway modulates survival, proliferation, and differentiation of neural progenitor cells under inflammatory stress in vitro Cells 2022 11 736 10.3390/cells11040736 35203385 PMC8869809 17. Kim T. Mondal S.C. Jeong C.R. Kim S.R. Ban O.H. Jung Y.H. Yang J. Kim S.J. Safety evaluation of Lactococcus lactis Food Sci. Nutr. 2022 10 67 74 10.1002/fsn3.2648 35035910 PMC8751446 18. Lee Y.R. Bang W.Y. Baek K.R. Kim G.H. Kang M.J. Yang J. Seo S.O. Safety evaluation by phenotypic and genomic characterization of four Lactobacilli strains with probiotic properties Microorganisms 2022 10 2218 10.3390/microorganisms10112218 36363810 PMC9696993 19. Bourgin M. Kriaa A. Mkaouar H. Mariaule V. Jablaoui A. Maguin E. Rhimi M. Bile salt hydrolases: At the crossroads of microbiota and human health Microorganisms 2021 9 1122 10.3390/microorganisms9061122 34067328 PMC8224655 20. Costarelli V. Key T. Appleby P. Allen D. Fentiman I. Sanders T. A prospective study of serum bile acid concentrations and colorectal cancer risk in post-menopausal women on the island of Guernsey Br. J. Cancer 2002 86 1741 1744 10.1038/sj.bjc.6600340 12087460 PMC2375402 21. Joung H. Chu J. Kwon Y.J. Kim K.H. Shin C.H. Ha J.H. Assessment of the safety and hepatic lipid-lowering effects of Lactobacillus delbrueckii Appl. Biol. Chem. 2024 67 101 10.1186/s13765-024-00949-9 22. Pradhan D. Singh R. Tyagi A. Rashmi H. Batish V. Grover S. Assessing safety of Lactobacillus plantarum Lactobacillus fermentum Regul. Toxicol. Pharmacol. 2019 101 1 11 10.1016/j.yrtph.2018.10.011 30367905 23. Varada V.V. Panneerselvam D. Pushpadass H.A. Mallapa R.H. Ram C. Kumar S. In vitro safety assessment of electrohydrodynamically encapsulated Lactiplantibacillus plantarum Lacticaseibacillus rhamnosus Curr. Res. Food Sci. 2023 6 100507 10.1016/j.crfs.2023.100507 37215740 PMC10196993 24. Zhou J. Gopal P. Gill H. Potential probiotic lactic acid bacteria Lactobacillus rhamnosus Lactobacillus acidophilus Bifidobacterium lactis Int. J. Food Microbiol. 2001 63 81 90 10.1016/S0168-1605(00)00398-6 11205957 25. Araújo C. Munoz-Atienza E. Ramírez M. Poeta P. Igrejas G. Hernández P.E. Herranz C. Cintas L.M. Safety assessment, genetic relatedness and bacteriocin activity of potential probiotic Lactococcus lactis Oncorhynchus mykiss Eur. Food Res. Technol. 2015 241 647 662 10.1007/s00217-015-2493-z 26. Song E.J. Lee E.S. Kim Y.I. Shin D.U. Eom J.E. Shin H.S. Lee S.Y. Nam Y.D. Gut microbial change after administration of Lacticaseibacillus paracasei Front. Endocrinol. 2023 14 1224636 10.3389/fendo.2023.1224636 PMC10496115 37705572 27. Łukasik J. Salminen S. Szajewska H. Rapid review shows that probiotics and fermented infant formulas do not cause d-lactic acidosis in healthy children Acta Paediatr. 2018 107 1322 1326 10.1111/apa.14338 29603358 28. Uchida H. Yamamoto H. Kisaki Y. Fujino J. Ishimaru Y. Ikeda H. D-lactic acidosis in short-bowel syndrome managed with antibiotics and probiotics J. Pediatr. Surg. 2004 39 634 636 10.1016/j.jpedsurg.2003.12.026 15065046 29. Jang Y.J. Gwon H.M. Jeong W.S. Yeo S.H. Kim S.Y. Safety evaluation of Weissella cibaria Microorganisms 2021 9 2450 10.3390/microorganisms9122450 34946052 PMC8704421 30. Stuivenberg G. Daisley B. Akouris P. Reid G. In vitro assessment of histamine and lactate production by a multi-strain synbiotic J. Food Sci. Technol. 2021 59 3419 3427 10.1007/s13197-021-05327-7 35875231 PMC9304488 31. Kim M.J. Ku S. Kim S.Y. Lee H.H. Jin H. Kang S. Li R. Johnston T.V. Park M.S. Ji G.E. Safety evaluations of Bifidobacterium bifidum Bifidobacterium longum Int. J. Mol. Sci. 2018 19 1422 10.3390/ijms19051422 29747442 PMC5983828 32. Capozzi V. Russo P. Ladero V. Fernández M. Fiocco D. Alvarez M.A. Grieco F. Spano G. Biogenic amines degradation by Lactobacillus plantarum Front. Microbiol. 2012 3 122 10.3389/fmicb.2012.00122 22485114 PMC3316997 33. Bin Hafeez A. Pełka K. Worobo R. Szweda P. In silico safety assessment of Bacillus Int. J. Mol. Sci. 2024 25 666 10.3390/ijms25010666 38203838 PMC10780176 34. Ku S. Yang S. Lee H.H. Choe D. Johnston T.V. Ji G.E. Park M.S. Biosafety assessment of Bifidobacterium animalis lactis Food Control 2020 117 106985 10.1016/j.foodcont.2019.106985 35. Yilmaz N. Quantitative analysis of biogenic amine production of different lactic acid bacteria isolated from ready-to-eat packaged fish products Vet. Res. Forum 2024 15 537 543 10.30466/vrf.2024.2024103.4193 39588461 PMC11585845 36. Chen T. Zhao Y. Fan Y. Dong Y. Gai Z. Genome sequence and evaluation of safety and probiotic potential of Lacticaseibacillus paracasei Lacticaseibacillus casei Front. Microbiol. 2025 15 1501502 10.3389/fmicb.2024.1501502 39931277 PMC11808145 37. Turna N.S. Chung R. McIntyre L. A review of biogenic amines in fermented foods: Occurrence and health effects Heliyon 2024 10 e24501 10.1016/j.heliyon.2024.e24501 38304783 PMC10830535 38. Rajasekaran J.J. Krishnamurthy H.K. Bosco J. Jayaraman V. Krishna K. Wang T. Bei K. Oral microbiome: A review of its impact on oral and systemic health Microorganisms 2024 12 1797 10.3390/microorganisms12091797 39338471 PMC11434369 39. Coppola R. Succi M. Tremonte P. Reale A. Salzano G. Sorrentino E. Antibiotic susceptibility of Lactobacillus rhamnosus Lait 2005 85 193 204 10.1051/lait:2005007 15727832 40. Imperial I.C. Ibana J.A. Addressing the antibiotic resistance problem with probiotics: Reducing the risk of its double-edged sword effect Front. Microbiol. 2016 7 1983 10.3389/fmicb.2016.01983 28018315 PMC5156686 41. Jiang Y.H. Yang R.S. Lin Y.C. Xin W.G. Zhou H.Y. Wang F. Zhang Q.L. Lin L.B. Assessment of the safety and probiotic characteristics of Lactobacillus salivarius Front. Microbiol. 2023 14 1120263 10.3389/fmicb.2023.1120263 37007532 PMC10062426 42. Kondrotiene K. Lauciene L. Andruleviciute V. Kasetiene N. Serniene L. Sekmokiene D. Malakauskas M. Safety assessment and preliminary in vitro evaluation of probiotic potential of Lactococcus lactis Curr. Microbiol. 2020 77 3013 3023 10.1007/s00284-020-02119-8 32683465 43. Colautti A. Arnoldi M. Comi G. Iacumin L. Antibiotic resistance and virulence factors in lactobacilli: Something to carefully consider Food Microbiol. 2022 103 103934 10.1016/j.fm.2021.103934 35082060 44. de Niederhäusern S. Bondi M. Messi P. Iseppi R. Sabia C. Manicardi G. Anacarso I. Vancomycin-resistance transferability from VanA enterococci to Staphylococcus aureus Curr. Microbiol. 2011 62 1363 1367 10.1007/s00284-011-9868-6 21234755 45. van Reenen C.A. Dicks L.M. Horizontal gene transfer amongst probiotic lactic acid bacteria and other intestinal microbiota: What are the possibilities? A review Arch. Microbiol. 2011 193 157 168 10.1007/s00203-010-0668-3 21193902 46. Im E.J. Lee H.H.Y. Kim M. Kim M.K. Evaluation of enterococcal probiotic usage and review of potential health benefits, safety, and risk of antibiotic-resistant strain emergence Antibiotics 2023 12 1327 10.3390/antibiotics12081327 37627747 PMC10451534 47. Mathur S. Singh R. Antibiotic resistance in food lactic acid bacteria—A review Int. J. Food Microbiol. 2005 105 281 295 10.1016/j.ijfoodmicro.2005.03.008 16289406 48. Zhang F. Jiang M. Wan C. Chen X. Chen X. Tao X. Shah N.P. Wei H. Screening probiotic strains for safety: Evaluation of virulence and antimicrobial susceptibility of enterococci from healthy Chinese infants J. Dairy Sci. 2016 99 4282 4290 10.3168/jds.2015-10690 26995141 49. Mortezaei M. Dadmehr M. Korouzhdehi B. Hakimi M. Ramshini H. Colorimetric and label free detection of gelatinase positive bacteria and gelatinase activity based on aggregation and dissolution of gold nanoparticles J. Microbiol. Methods 2021 191 106349 10.1016/j.mimet.2021.106349 34699865 50. Koksharova O.A. Butenko I.O. Pobeguts O.V. Safronova N.A. Govorun V.M. β-N-methylamino-L-alanine (BMAA) causes severe stress in Nostoc Toxins 2021 13 325 10.3390/toxins13050325 33946501 PMC8147232 51. Lee C.S. Park M.H. Kim S.H. Selection and characterization of probiotic bacteria exhibiting antiadipogenic potential in 3T3-L1 preadipocytes Probiotics Antimicrob. Proteins 2022 14 72 86 10.1007/s12602-021-09793-5 33961206 PMC8103433 52. Jaglin M. Rhimi M. Philippe C. Pons N. Bruneau A. Goustard B. Daugé V. Maguin E. Naudon L. Rabot S. Indole, a signaling molecule produced by the gut microbiota, negatively impacts emotional behaviors in rats Front. Neurosci. 2018 12 216 10.3389/fnins.2018.00216 29686603 PMC5900047 53. Li Q.q. Zeng S.p. Liang M.h. Yousaf M. Wu Y.p. Tang J. Xiong J. Liu D.m. Safety and metabolism characteristics of Lacticaseibacillus rhamnosus LWT 2024 204 116443 10.1016/j.lwt.2024.116443 54. Lee D.Y. Seo Y.S. Rayamajhi N. Kang M.L. Lee S.I. Yoo H.S. Isolation, characterization, and evaluation of wild isolates of Lactobacillus reuteri J. Microbiol. 2009 47 663 672 10.1007/s12275-009-0124-8 20127457 Figure 1 Hemolytic activity of bacterial strains. (a) S. pneumoniae S. pyogenes S. agalactiae L. buchneri KU200793 Figure 2 Bile salt deconjugation test. ( a Lp. plantarum b L. buchneri KU200793 Figure 3 Effect of L. buchneri KU200793 L. buchneri KU200793 K. pneumoniae pneumoniae p Figure 4 Mucin degradation activity of L. buchneri KU200793 a b c d p Figure 5 E-test for the determination of antibiotic resistance. microorganisms-13-02067-t001_Table 1 Table 1 D-Lactic acid production of Lentilactobacillus buchneri KU200793 Strain D-Lactic Acid (mM) L. buchneri KU200793 2.0 ± 0.3 The data are expressed as mean ± SD ( n microorganisms-13-02067-t002_Table 2 Table 2 Biogenic amine production of Lentilactobacillus buchneri KU200793 Biogenic Amines Concentration (ppm) Agmatine n.d. * β-phenylethylamine n.d. Putrescine n.d. Histamine n.d. Serotonin n.d. Spermidine 15.3 ± 7.0 Tryptamine n.d. Tyramine n.d. * n.d.: Not detected. The data are expressed as mean ± SD ( n microorganisms-13-02067-t003_Table 3 Table 3 Minimum inhibitory concentration and antibiotic susceptibility of Lentilactobacillus buchneri KU200793 Antibiotics Cut-Off Value (µg/mL) * MIC (µg/mL) Assessment Ampicillin 2 0.38 S *** Vancomycin n.r. ** - - Gentamycin 16 0.047 S Kanamycin 32 1 S Streptomycin 64 0.5 S Erythromycin 1 0.016 S Clindamycin 1 0.016 S Tetracycline 8 48 R **** Chloramphenicol 4 1 S * Cut-off value based on European Food Safety Authority guidelines; ** n.r., not required; *** S, Susceptible; **** R, Resistant. microorganisms-13-02067-t004_Table 4 Table 4 Results of antibiotic resistance gene analysis based on genome sequence data. RGI Criteria ARO Term AMR Gene Family Drug Class % Identity Matching Region Loose tetA 58 Major facilitator superfamily antibiotic efflux pump tetracycline antibiotic 33.64  nalD Resistance-nodulation-cell division antibiotic efflux pump macrolide antibiotic, fluoroquinolone antibiotic, monobactam, carbapenem, cephalosporin, cephamycin, penam, tetracycline antibiotic, peptide antibiotic, aminocoumarin antibiotic, diaminopyrimidine antibiotic, sulfonamide antibiotic, phenicol antibiotic, penem 30.17 ",
  "metadata": {
    "Title of this paper": "Isolation, characterization, and evaluation of wild isolates of ",
    "Journal it was published in:": "Microorganisms",
    "URL": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12472085/"
  }
}